Tango Therapeutics logo

Tango Therapeutics

Tango Therapeutics is a cancer Therapeutics, Immuno-Oncology.

3

Funding Rounds

$165.0m

Money raised

Overview

Tango Therapeutics is a cancer Therapeutics, Immuno-Oncology.

Funding

Funding series

Funding Series Analysis

The company Tango Therapeutics has raised a total of $165m in funding over 3 rounds.

Key Insights:

  • Tango Therapeutics , August 2020: $50m
  • Tango Therapeutics Series B round, April 2020: $60m
  • Tango Therapeutics Series A round, March 2017: $55m
Tango Therapeutics logo
Tango Therapeutics , August 2020 $50m
Tango Therapeutics logo
Tango Therapeutics Series B round, April 2020 $60m
Tango Therapeutics logo
Tango Therapeutics Series A round, March 2017 $55m

Industries

Tango Therapeutics is active in the following industries:
  • Engineering
  • Biomedical engineering
  • Chemistry
  • Enzyme kinetics
  • Technology
  • Biology
  • Biotechnology